A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults

Bipolar Disorders

Volumn 17, Issue 6, 2015, Pages 575-597

  Jackson, James G ^a   Diaz, Francisco J ^b   Lopez, Lucelly ^c   de Leon, Jose ^d,e,f  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSIDAD PONTIFICIA BOLIVARIANA   (Colombia)

^d Eastern State Hospital   (United States)

^e UNIVERSITY OF GRANADA   (Spain)

^f UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Bipolar disorder; Major depression; Meta analysis; Nicotine; Schizophrenia; Smoking; Tobacco

Indexed keywords

NICOTINE;

ADULT; BIPOLAR DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PREVALENCE; PRIORITY JOURNAL; PSYCHOMETRY; REVIEW; SCHIZOPHRENIA; SIGNAL NOISE RATIO; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; ODDS RATIO; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; HUMANS; ODDS RATIO; PREVALENCE; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SMOKING; SMOKING CESSATION;

EID: 84941023503     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12319     Document Type: Review

References (126)

1. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York: Oxford University Press, 1990.
2. Goodwin FK, Jamison KR. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, 2nd edn. New York: Oxford University Press, 2007.
3. Diaz FJ, James D, Botts S, Maw L, Susce MT, de Leon J. Tobacco smoking behaviors in bipolar disorder: a comparison with the general population, schizophrenia, and major depression. Bipolar Disord 2009; 11: 154-165.
4. de Leon J, Diaz FJ. Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings. Hum Genet 2012; 131: 877-901.
5. de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry 1995; 152: 453-455.
6. Birkenaes AB, Opjordsmoen S, Brunborg C et al. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry 2007; 68: 917-923.
7. Cassidy F, McEvoy JP, Yang YK, Wilson WH. Smoking and psychosis in patients with bipolar I disorder. Compr Psychiatry 2002; 43: 63-64.
8. Chandra PS, Carey MP, Carey KB et al. Prevalence and correlates of tobacco use and nicotine dependence among psychiatric patients in India. Addict Behav 2005; 30: 1290-1299.
9. Corvin A, O'Mahony E, O'Regan M et al. Cigarette smoking and psychotic symptoms in bipolar affective disorder. Br J Psychiatry 2001; 179: 35-38.
10. Gerber GJ, Krupa T, Eastabrook S, Gargaro J. Substance use among persons with serious mental illness in eastern Ontario. Can J Commun Ment Health 2003; 22: 113-128.
11. Gonzalez-Pinto A, Gutierrez M, Ezcurra J et al. Tobacco smoking and bipolar disorder. J Clin Psychiatry 1998; 59: 225-228.
12. Hippisley-Cox J, Parker C, Coupland C, Vinogradova Y. Inequalities in the primary care of patients with coronary heart disease and serious mental health problems: a cross-sectional study. Heart 2007; 93: 1256-1262.
13. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 1986; 143: 993-997.
14. Morris CD, Giese AA, Turnbull JJ, Dickinson M, Johnson-Nagel N. Predictors of tobacco use among persons with mental illnesses in a statewide population. Psychiatr Serv 2006; 57: 1035-1038.
15. Ostacher MJ, Nierenberg AA, Perlis RH et al. The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. J Clin Psychiatry 2006; 67: 1907-1911.
16. Ucok A, Polat A, Bozkurt O, Meteris H. Cigarette smoking among patients with schizophrenia and bipolar disorders. Psychiatry Clin Neurosci 2004; 58: 434-437.
17. Vanable PA, Carey MP, Carey KB, Maisto SA. Smoking among psychiatric outpatients: relationship to substance use, diagnosis, and illness severity. Psychol Addict Behav 2003; 17: 259-265.
18. Waxmonsky JA, Thomas MR, Miklowitz DJ et al. Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the Systematic Treatment Enhancement Program. Gen Hosp Psychiatry 2005; 27: 321-328.
19. Yates WR, Wallace R. Cardiovascular risk factors in affective disorder. J Affect Disord 1987; 12: 129-134.
20. Dome P, Rihmer Z, Gonda X et al. Cigarette smoking and psychiatric disorders in Hungary. Int J Psychiatry Clin Pract 2005; 9: 145-148.
21. Dodd S, Brnabic AJM, Berk L et al. A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder. Compr Psychiatry 2010; 51: 504-509.
22. Novak G, Zai CC, Mirkhani M et al. Replicated association of the NRa43 gene with smoking behaviour in schizophrenia and bipolar disorder. Genes Brain Behav 2010; 9: 910-917.
23. Guan N, Liu H, Diao F et al. Prevalence of metabolic syndrome in bipolar patients initiating acute-phase treatment: a 6-month follow up. Psychiatry Clin Neurosci 2010; 64: 625-633.
24. Pattanayak RD, Sagar R, Jain R. Perceived health risks, attitude and readiness to quit tobacco among euthymic bipolar disorder patients in regular contact with mental health services: an exploratory study from India. J Ment Health 2012; 21: 83-90.
25. Kreinin A, Novitski D, Rabinowitz D, Weizman A, Grinshpoon A. Association between tobacco smoking and bipolar affective disorder: clinical, epidemiological, cross-sectional, retrospective study in outpatients. Compr Psychiatry 2012; 53: 269-274.
26. Maremmani I, Perugi G, Rovai L et al. Are "social drugs" (tobacco, coffee and chocolate) related to the bipolar spectrum? J Affect Disord 2011; 133: 227-233.
27. Baethge C, Tondo L, Lepri B, Baldessarini RJ. Coffee and cigarette use: association with suicidal acts in 352 Sardinian bipolar disorder patients. Bipolar Disord 2009; 11: 494-503.
28. Heffner JL, DelBello MP, Fleck DE, Anthenelli RM, Strakowski SM. Cigarette smoking in the early course of bipolar disorder: association with ages-at-onset of alcohol and marijuana use. Bipolar Disord 2008; 10: 838-845.
29. Ostacher MJ, LeBeau RT, Perlis RH et al. Cigarette smoking is associated with suicidality in bipolar disorder. Bipolar Disord 2009; 11: 766-771.
30. McClave AK, McKnightly-Eily LR, Davis SP, Dube SR. Smoking characteristics of adults with selected lifetime mental illness: results from the 2007 national health interview survey. Am J Public Health 2010; 100: 2464-2472.
31. Dickerson F, Stallings CR, Origoni AE et al. Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999-2011. Psychiatr Serv 2013; 64: 44-50.
32. Smith DJ, Nicholl BI, Cullen B et al. Prevalence and characteristics of probable major depression and bipolar disorder within UK Biobank: cross-sectional study of 172, 751 participants. PLoS ONE 2013; 8: e75362.
33. Itkin O, Nemets B, Einat H. Smoking habits in bipolar and schizophrenic outpatients in southern Israel. J Clin Psychiatry 2002; 63: 368-369.
34. de Leon J, Tracy J, McCann E, McGrory A, Diaz FJ. Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital. Schizophr Res 2002; 56: 55-65.
35. Kim B, Kim SJ, Son JI, Joo YH. Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients. J Affect Disord 2008; 105: 45-52.
36. Kotov R, Guey LT, Bromet EJ, Schwartz JE. Smoking in schizophrenia: diagnostic specificity, symptom correlates, and illness severity. Schizophr Bull 2010; 36: 173-181.
37. Garcia-Portilla MP, Saiz PA, Bascaran MT et al. Cardiovascular risk in patients with bipolar disorder. J Affect Disord 2009; 115: 302-308.
38. Neves FS, Malloy-Diniz LF, Corrêa H. Suicidal behavior in bipolar disorder: what is the influence of psychiatric comorbidities? J Clin Psychiatry 2009; 70: 13-18.
39. Goldstein BI, Fagiolini A, Houck P, Kupfer DJ. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disord 2009; 11: 657-662.
40. González-Estecha M, Trasobares EM, Tajima K et al. Trace elements in bipolar disorder. J Trace Elem Med Biol 2011; 25 (Suppl. 1): S78-S83.
41. Vemuri M, Kenna HA, Wang PW, Ketter TA, Rasgon NL. Gender-specific lipid profiles in patients with bipolar disorder. J Psychiatr Res 2011; 45: 1036-1041.
42. Chwastiak LA, Rosenheck RA, Kazis LE. Association of psychiatric illness and obesity, physical inactivity, and smoking among a national sample of veterans. Psychosomatics 2011; 52: 230-236.
43. Magalhães PV, Kapczinski F, Nierenberg AA et al. Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder. Acta Psychiatr Scand 2012; 125: 303-308.
44. Saiyad M, El-Mallakh RS. Smoking is associated with greater symptom load in bipolar disorder patients. Ann Clin Psychiatry 2012; 24: 305-309.
45. Baek JH, Eisner LR, Nierenberg AA. Smoking and suicidality in subjects with bipolar disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Depress Anxiety 2013; 30: 982-990.
46. Baek JH, Eisner LR, Nierenberg AA. Smoking and suicidality in subjects with major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Affect Disord 2013; 150: 1158-1166.
47. Gomes FA, Almeida KM, Magalhães PV et al. Cardiovascular risk factors in outpatients with bipolar disorder: a report from the Brazilian Research Network in Bipolar Disorder. Rev Bras Psiquiatr 2013; 35: 126-130.
48. Lagerberg TV, Kvitland LR, Aminoff SR et al. Indications of a dose-response relationship between cannabis use and age at onset in bipolar disorder. Psychiatry Res 2014; 215: 101-104.
49. Hartz SM, Pato CN, Medeiros H et al. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry 2014; 71: 248-254.
50. Hirasawa-Fujita M, Bly MJ, Ellingrod VL, Dalack GW, Domino EF. Genetic variation of the mu opioid receptor (OPRM1) and dopamine D2 receptor (DRD2) is related to smoking differences in patients with schizophrenia but not bipolar disorder. Clin Schizophr Relat Psychoses 2014; 20: 1-27.
51. Ezquiaga E, García-López A, de Dios C, Agud JL, Albillo D, Vega-Piris L. Seasonality, smoking and history of poor treatment compliance are strong predictors of dropout in a naturalistic 6 year follow-up of bipolar patients. Psychiatr Q 2014; 85: 467-477.
52. Sylvia LG, Shelton RC, Kemp DE et al. Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE). Bipolar Disord 2015; 17: 212-223.
53. Black DW, Zimmerman M, Coryell WH. Cigarette smoking and psychiatric disorder in a community sample. Ann Clin Psychiatry 1999; 11: 129-136.
54. de Leon J, Diaz FJ, Rogers T, Browne D, Dinsmore L. Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders. Schizophr Res 2002; 56: 47-54.
55. Lasser K, Boyd JW, Woolhandler S et al. Smoking and mental illness: a population-based prevalence study. JAMA 2000; 284: 2606-2610.
56. Ratto LR, Menezes PR, Gulinelli A. Prevalence of tobacco use in individuals with severe mental illnesses, Sao Paulo, Brazil. Rev Saude Publica 2007; 41: 510-516.
57. Ezzaher A, Haj MD, Mechri A et al. Metabolic syndrome in Tunisian bipolar I patients. Afr Health Sci 2011; 11: 414-420.
58. Cooper J, Mancuso SG, Borland R, Slade T, Galletly C, Castle D. Tobacco smoking among people living with a psychotic illness: the second Australian Survey of Psychosis. Aust N Z J Psychiatry 2012; 46: 851-863.
59. Williams JM, Gandhi KK, Lu SE, Steinberg ML, Benowitz NL. Nicotine intake and smoking topography in smokers with bipolar disorder. Bipolar Disord 2012; 14: 618-627.
60. Williams JM, Gandhi KK, Benowitz NL. Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness. Cancer Epidemiol Biomarkers Prev 2010; 19: 2582-2589.
61. George TP, Wu BS, Weinberger AH. A Review of smoking cessation in bipolar disorder: implications for future research. J Dual Diagn 2012; 8: 126-130.
62. Weinberger AH, Vessicchio JC, Sacco KA, Creeden CL, Chengappa KN, George TP. A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder. J Clin Psychopharmacol 2008; 28: 584-587.
63. Filia SL, Baker AL, Kulkarni J, Williams JM. Sequential behavioral treatment of smoking and weight control in bipolar disorder. Transl Behav Med 2012; 2: 290-295.
64. Heffner JL, Anthenelli RM, DelBello MP, Stahl L, Strakowski SM. Mood management and nicotine patch for smoking cessation in adults with bipolar disorder. Nicotine Tob Res 2013; 15: 1805-1806.
65. Wu BS, Weinberger AH, Mancuso E et al. A preliminary feasibility study of varenicline for smoking cessation in bipolar disorder. J Dual Diagn 2012; 8: 131-132.
66. Frye MA, Ebbert JO, Prince CA, Lineberry TW, Geske JR, Patten CA. A feasibility study of varenicline for smoking cessation in bipolar patients with subsyndromal depression. J Clin Psychopharmacol 2013; 33: 821-823.
67. Evins AE, Cather C, Pratt SA et al. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial. JAMA 2014; 311: 145-154.
68. Chengappa KN, Perkins KA, Brar JS et al. Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2014; 75: 765-772.
69. Vinogradova Y, Coupland C, Hippisley-Cox J, Whyte S, Penny C. Effects of severe mental illness on survival of people with diabetes. Br J Psychiatry 2010; 197: 272-277.
70. Diwan A, Castine M, Pomerlau CS, Meador-Woodruff JH, Dalack GW. Different prevalence of cigarette smoking in patients with schizophrenia vs. mood disorders. Schizophr Res 1998; 33: 113-118.
71. de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 2005; 76: 135-157.
72. de Leon J, Gurpegui M, Diaz FJ. Epidemiology of comorbid tobacco use and schizophrenia: thinking about risks and protective factors. J Dual Diag 2007; 3: 9-25.
73. Haddock CK, Lando H, Klesges RC, Talcott GW, Renaud EA. A study of the psychometric and predictive properties of the Fagerström Test for Nicotine Dependence in a population of young smokers. Nicotine Tob Res 1999; 1: 59-66.
74. Kozlowski LT, Porter CQ, Orleans CT, Pope MA, Heatherton T. Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug Alcohol Depend 1994; 34: 211-216.
75. Payne TJ, Smith PO, McCracken LM, McSherry WC, Antony MM. Assessing nicotine dependence: a comparison of the Fagerström Tolerance Questionnaire (FTQ) with the Fagerström Test for Nicotine Dependence (FTND) in a clinical sample. Addict Behav 1994; 19: 307-317.
76. Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, Pomerleau OF. Reliability of the Fagerström Tolerance Questionnaire and the Fagerström Test for Nicotine Dependence. Addict Behav 1994; 19: 33-39.
77. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes per day. Br J Addict 1998; 84: 791-800.
78. Fagerström KO, Kunze M, Schoberberger R et al. Nicotine dependence versus smoking prevalence: comparison among countries and categories of smokers. Tob Control 1996; 5: 52-56.
79. de Leon J, Becoña E, Gurpegui M, Gonzalez-Pinto A, Diaz FJ. The association between high nicotine dependence and severe mental illness may be consistent across countries. J Clin Psychiatry 2002; 63: 812-816.
80. de Leon J, Diaz FJ, Becoña E, Gurpegui M, Jurado D, Gonzalez-Pinto A. Exploring brief measures of nicotine dependence. Addict Behav 2002; 28: 1481-1486.
81. Diaz FJ, Jané M, Saltó E et al. A brief measure of high nicotine dependence for busy clinicians and large epidemiological surveys. Aust NZ J Psychiatry 2005; 39: 161-168.
82. Chabrol H, Niezborala M, Chastan E, de Leon J. Comparison of the Heavy Smoking Index and of the Fagerstrom Test for Nicotine Dependence in a sample of 749 cigarette smokers. Addict Behav 2005; 30: 1474-1477.
83. de Leon J, Diaz FJ. Smoking in bipolar and schizophrenic patients (letter). J Clin Psychiatry 2002; 63: 368-369.
84. Giovino GA, Schooley MW, Zhu B-P et al. Surveillance for selected tobacco-use behaviors - United States, 1900-1994. MMWR 1994; 43: 1-43.
85. Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults - United States, 1988. MMWR 1991; 40: 757-759.
86. Centers for Disease Control and Prevention (CDC). State-specific prevalence of current cigarette smoking among adults - United States, 2002. MMWR 2004; 53: 1277-1280.
87. Centers for Disease Control and Prevention (CDC). State-specific prevalence of cigarette smoking and quitting among adults - United States, 2004. MMWR 2005; 54: 1124-1230.
88. Leach RC. Kentucky Behavioral Risk Factor Surveillance System: 2001 Report. Frankfort, KY: Kentucky Department for Public Health. Division of Epidemiology and Health Planning, 2003.
89. Corrao MA, Guindon GE, Sharma N et al. eds. Tobacco Control: Country Profiles. Atlanta, GA: American Cancer Society, 2000.
90. Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults - United States, 1993. MMWR 1994; 43: 925-930.
91. Yue C, Fleiszer P. Toronto's Health Status 2010. Toronto, ON: Toronto's Public Health, 2010.
92. Li Q, Hsai J, Yang G. Prevalence of smoking in China in 2010. N Engl J Med 2011; 364: 2469-2470.
93. Giovino GA, Mirza SA, Samet JM et al. Tobacco use in 3 billion individuals: an analysis of nationally representative cross-sectional surveys. Lancet 2012; 380: 668-679.
94. Gallus S, Zuccaro P, Colombo P et al. Smoking in Italy in 2005-2006: effects of a comprehensive National Tobacco Regulation. Prev Med 2007; 45: 198-201.
95. World Health Organization (WHO). WHO Report on the Global Tobacco Epidemic, 2009: Implementing Smoke-Free Environments. Geneva, Switzerland: World Health Organization, 2009: E254.
96. Centers for Disease Control and Prevention. (CDC). State-specific prevalence of current cigarette smoking among adults, and policies and attitudes about secondhand smoke - United States, 2000. MMWR Morb Mortal Wkly Rep 2001; 50: 1101-1116.
97. Roncati R, Tononi AM. Italy in Figures, 2009. Rome: Italian National Institute of Statistics, Division for Communication and Publishing, 2009.
98. Israel Center for Disease Control. Minister of Health's Report on Smoking in Israel 2013. Public Health Services. Ministry of Health, 2014 (in Hebrew). Available from: http://www.health.gov.il/PublicationsFiles/smoking_2013.pdf [accessed December 2014].
99. Ministerio de Sanidad Politica y Social e Igualdad. Informe anual del Sistema Nacional de Salud, 2008. Madrid: Ministerio de Sanidad, Política Social e Igualdad, 2010. Available from: http://www.msssi.gob.es/organizacion/sns/planCalidadSNS/isns2008.htm [accessed December 2014].
100. Australian Institute of Health and Welfare. 2010 National Drug Strategy Household Survey Report. Drug statistics series no. 25. Cat. no. PHE 145. Canberra: AIHW, 2011.
101. Opaleye ES, Sanchez ZM, Moura YG, Galduróz JC, Locatelli DP, Noto AR. The Brazilian smoker: a survey in the largest cities of Brazil. Rev Bras Psiquiatr 2012; 34: 43-51.
102. Ko M, Kim MT, Nam JJ. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey. Int J Cardiol 2006; 110: 184-190.
103. Forey B, Hamling J, Thornton A, Lee P. International Smoking Statistics Web Edition. A Collection of Worldwide Historical Data. Norway Date of issued 4-Oct-2012. This report is an updated version of Chapter 20 of International Smoking Statistics 2nd edition, Wolfson Institute of Preventive Medicine and OUP, 2002. Available from: http://ukcatalogue.oup.com/product/9780198508564.do [accessed December 2014].
104. Daldoul H, Denguezli M, Jithoo A et al. Prevalence of COPD and tobacco smoking in Tunisia - results from the BOLD study. Int J Environ Res Public Health 2013; 10: 7257-7271.
105. California Department of Public Health, California Tobacco Control Program. Adult Smoking Prevalence. Sacramento, CA: California Department of Public Health, 2010. Available from: http://www.cdph.ca.gov/programs/tobacco/Pages/CTCPPublications.aspx [accessed December 2014].
106. Al-Delaimy WK, White MM, Mills AL et al. Final Summary Report of: Two Decades of the California Tobacco Control Program: California Tobacco Survey, 1990-2008, La Jolla, CA. San Diego: CA: University of California, San Diego, 2010. Available from: http://www.cdph.ca.gov/programs/tobacco/Pages/CTCPPublications.aspx [accessed December 2014].
107. Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults - United States, 2002. MMWR Morb Mortal Wkly Rep 2004; 53: 427-431.
108. Centers for Disease Control and Prevention (CDC). State-specific prevalence of cigarette smoking and smokeless tobacco use among adults - United States, 2009. MMWR Morb Mortal Wkly Rep 2010; 59: 1400-1406.
109. Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults-United States, 2001. MMWR Morb Mortal Wkly Rep 2003; 52: 953-956.
110. Centers for Disease Control and Prevention (CDC). Current cigarette smoking among adults - United States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61: 889-894.
111. Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults - United States, 2000. MMWR Morb Mortal Wkly Rep 2002; 51: 642-645.
112. U.S. Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014. Available from: http://www.surgeongeneral.gov/library/reports/50-years-of-progress/index.html [accessed December 2014].
113. de Leon J, Susce MT, Diaz FJ, Rendon DM, Velasquez DM. Variables associated with alcohol, drug and daily smoking cessation in patients with severe mental illnesses. J Clin Psychiatry 2006; 66: 1447-1455.
114. de Leon J, Rendon DM, Baca-Garcia E et al. Association between smoking and alcohol use in the general population: stable and unstable odds ratios across two years in two different countries. Alcohol 2007; 42: 252-257.
115. Campo A, Díaz LA, Rueda GE, Rueda M, Farelo D. Prevalencia de consumo de cigarrillo en pacientes de la consulta psiquiátrica de Bucaramanga. Colombia Médica 2004; 35: 69-74.
116. Campo-Arias A, Díaz-Martínez LA, Rueda-Jaimes GE et al. Smoking is associated with schizophrenia, but not with mood disorders, within a population with low smoking rates: a matched case-control study in Bucaramanga, Colombia. Schizophr Res 2006; 83: 269-276.
117. SPSS Inc. SPSS 22.0, Applications Guide. Chicago, IL: SPPS Inc., 2014.
118. StataCorp. Stata: Release 13. Statistical Software. College Station, TX: StataCorp LP, 2013.
119. Wilcox RR. Fundamentals of Modern Statistical Methods. New York: Springer-Verlag, 2001.
120. Casella G, Berger RL. Statistical Inference, 2nd edn. Pacific Grove, CA: Duxbury, 2002.
121. Cytel Software Co. LogXact-7 User Manual. Cambridge: Cytel Software Co., 2005.
122. Bailar JC. The practice of meta-analysis. J Clin Epidemiol 1995; 48: 149-157.
123. Greenhalgh T. Papers that summarise other papers (systematic reviews and meta-analyses). BMJ 1997; 315: 672-675.
124. Shapiro S. Is meta-analysis a valid approach to the evaluation of small effects in observational studies? J Clin Epidemiol 1997; 50: 223-229.
125. Martínez-Ortega JM, Jurado D, Gurpegui M. Nicotine dependence vs. daily smoking as a meaningful variable: implications for clinical and epidemiological psychiatric studies. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1972-1977.
126. Egmont-Petersen M, Talmon JL, Hasman A. Robustness metrics for measuring the influence of additive noise on the performance of statistical classifiers. Int J Med Inform 1997; 46: 103-112.